Beyond the Golden Years: Young COPD and Early Lung Function Decline as Critical Drivers of Premature Mortality and Cardiovascular Risk

The Emerging Challenge of Early-Onset Respiratory Impairment

Chronic obstructive pulmonary disease (COPD) has traditionally been framed as a disease of the elderly, a culmination of decades of noxious exposures and biological aging. However, this paradigm is shifting as clinical research increasingly identifies a significant cohort of younger adults who manifest spirometric obstruction and respiratory symptoms. Identifying ‘young COPD’—diagnosed before age 50—is not merely an academic exercise; it represents a critical window for intervention that could alter the trajectory of a patient’s life. Two landmark studies recently published in NEJM Evidence and The Lancet Respiratory Medicine provide a compelling look at the prevalence, prognostic significance, and life-course trajectories of early-onset lung impairment, challenging clinicians to rethink how we screen and manage respiratory health in young and middle-aged adults.

Defining and Quantifying Young COPD: The NEJM Evidence Study